Abstract
Background
We have recognized a unique clinical syndrome in patients with upper gastrointestinal bleeding who are found to have severe esophagitis.
Aim
We aimed to more clearly describe the clinical entity of upper gastrointestinal bleeding in patients with severe esophagitis.
Methods
We conducted a retrospective matched case–control study designed to investigate clinical features in patients with carefully defined upper gastrointestinal bleeding and severe esophagitis. Patient data were captured prospectively via a Gastrointestinal Bleeding Healthcare Registry, which collects data on all patients admitted with gastrointestinal bleeding. Patients with endoscopically documented esophagitis (cases) were matched with randomly selected controls that had upper gastrointestinal bleeding caused by other lesions.
Results
Epidemiologic features in patients with esophagitis were similar to those with other causes of upper gastrointestinal bleeding. However, hematemesis was more common in patients with esophagitis 86 % (102/119) than in controls 55 % (196/357) (p < 0.0001), while melena was less common in patients with esophagitis 38 % (45/119) than in controls 68 % (244/357) (p < 0.0001). Additionally, the more severe the esophagitis, the more frequent was melena. Patients with esophagitis had less abnormal vital signs, lesser decreases in hematocrit, and lesser increases in BUN. Both pre- and postRockall scores were lower in patients with esophagitis compared with controls (p = 0.01, and p < 0.0001, respectively). Length of hospital stay (p = 0.002), rebleeding rate at 42 days (p = 0.0007), and mortality were less in patients with esophagitis than controls. Finally, analysis of patients with esophagitis and cirrhosis suggested that this group of patients had more severe bleeding than those without cirrhosis.
Conclusions
We have described a unique clinical syndrome in patients with upper gastrointestinal bleeding who have erosive esophagitis. This syndrome is manifest by typical clinical features and is associated with favorable outcomes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rockey DC. Gastrointestinal bleeding. Gastroenterol Clin N Am. 2005;34:581–588.
Acosta RD, Wong RK. Differential diagnosis of upper gastrointestinal bleeding proximal to the ligament of Trietz. Gastrointest Endosc Clin N Am. 2011;21:555–566.
Zimmerman J, Shohat V, Tsvang E, Arnon R, Safadi R, Wengrower D. Esophagitis is a major cause of upper gastrointestinal hemorrhage in the elderly. Scand J Gastroenterol. 1997;32:906–909.
Thomopoulos K, Katsakoulis E, Vagianos C, Mimidis K, Margaritis V, Nikolopoulou V. Causes and clinical outcome of acute upper gastrointestinal bleeding: a prospective analysis of 1534 cases. Int J Clin Pract. 1998;52:547–550.
Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J. Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med. 1999;27:2812–2817.
Kusano M, Ino K, Yamada T, et al. Interobserver and intraobserver variation in endoscopic assessment of GERD using the “Los Angeles” classification. Gastrointest Endosc. 1999;49:700–704.
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–180.
Newton M, Burnham WR, Kamm MA. Morbidity, mortality, and risk factors for esophagitis in hospital inpatients. J Clin Gastroenterol. 2000;30:264–269.
Sugiura T, Iwakiri K, Kotoyori M, Kobayashi M. Relationship between severity of reflux esophagitis according to the Los Angeles classification and esophageal motility. J Gastroenterol. 2001;36:226–230.
Spigelman AD, McGrath DR, Levy RD. Gastrointestinal surgery. Med J Aust. 2002;176:15.
Chalasani N, Clark WS, Wilcox CM. Blood urea nitrogen to creatinine concentration in gastrointestinal bleeding: a reappraisal. Am J Gastroenterol. 1997;92:1796–1799.
Al-Naamani K, Alzadjali N, Barkun AN, Fallone CA. Does blood urea nitrogen level predict severity and high-risk endoscopic lesions in patients with nonvariceal upper gastrointestinal bleeding? Can J Gastroenterol. 2008;22:399–403.
Balderas V, Bhore R, Lara LF, Spesivtseva J, Rockey DC. The hematocrit level in upper gastrointestinal hemorrhage: safety of endoscopy and outcomes. Am J Med. 2011;124:970–976.
Enestvedt BK, Gralnek IM, Mattek N, Lieberman DA, Eisen G. An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointest Endosc. 2008;67:422–429.
Kovacs TO, Jensen DM. The short-term medical management of non-variceal upper gastrointestinal bleeding. Drugs. 2008;68:2105–2111.
Loperfido S, Baldo V, Piovesana E, et al. Changing trends in acute upper-GI bleeding: a population-based study. Gastrointest Endosc. 2009;70:212–224.
Tsoi KK, Ma TK, Sung JJ. Endoscopy for upper gastrointestinal bleeding: how urgent is it? Nat Rev Gastroenterol Hepatol. 2009;6:463–469.
Rockey DC. Occult and obscure gastrointestinal bleeding: causes and clinical management. Nat Rev Gastroenterol Hepatol. 2010;7:265–279.
Conflict of interest
The authors certify that we have no financial arrangements (e.g., consultancies, stock ownership, equity interests, patent-licensing arrangements, research support, honoraria, etc.) with a company whose product figures prominently in this manuscript or with a company making a competing product.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guntipalli, P., Chason, R., Elliott, A. et al. Upper Gastrointestinal Bleeding Caused by Severe Esophagitis: A Unique Clinical Syndrome. Dig Dis Sci 59, 2997–3003 (2014). https://doi.org/10.1007/s10620-014-3258-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-014-3258-4